🔎 Trials Near Me

Akèy › Limfom Selil-T › Oregon › Portland

Etid klinik pou Limfom Selil-T nan Portland, OR

4 etid pou Limfom Selil-T ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Ap rekriteFaz 3
  • Oregon Health & Science University; Knight Cancer Institute, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06561048

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Ap rekriteFaz 3
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06724237

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Ap rekriteFaz 2
  • Oregan Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Oct 3, 2025 · NCT06534060

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Oregon Health & Science University, Portland
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Limfom Selil-T nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.